Proton Pump Inhibitor Use Linked to a Modestly Increased Dementia Risk in Older Adults: Study
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
South Korea: A meta-analysis of nearly two dozen studies, published in Clinical Pharmacology & Therapeutics, has found that proton pump inhibitor (PPI) use in older adults was associated with a modestly increased risk of developing incident dementia.
The findings highlight the need to periodically reassess long-term PPI therapy in older adults and prescribe these drugs only when clinically indicated. However, the observed association does not establish a causal relationship between PPI use and dementia.
The study was conducted by Heonyoung Ha, Graduate Program of Industrial Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea, and colleagues.
PPIs are widely prescribed to manage gastrointestinal conditions, including gastroesophageal reflux disease and peptic ulcer disease. However, concerns have emerged regarding their potential association with cognitive decline and dementia. Previous observational studies have reported inconsistent findings, making it difficult to establish whether prolonged PPI exposure independently contributes to dementia risk.
To investigate this association, researchers conducted an updated systematic review and meta-analysis of longitudinal observational studies. They searched MEDLINE, Embase, and CENTRAL databases from inception through January 25, 2026. The analysis included studies involving older adults without dementia at baseline, comparing dementia outcomes among PPI users and individuals receiving alternative treatments or no PPIs.
A total of 23 studies met the eligibility criteria. The researchers also performed subgroup and additional analyses to determine whether differences in comparator medications and methods of accounting for time-related biases influenced the observed association.
The analysis revealed the following findings:
- Overall dementia risk: PPI use was associated with an 18% higher risk of incident dementia compared with the respective comparator groups (HR 1.18).
- Comparison with alternative medication: When PPI users were compared specifically with individuals taking histamine-2 receptor antagonists (H2RAs), no significant difference in dementia risk was observed (HR 1.04).
- H2RA-associated risk: An additional analysis found that H2RA use itself was associated with increased dementia risk (HR 1.44).
- Excluding H2RA users: Removing individuals receiving H2RAs from the comparison strengthened the association between PPI use and dementia, with a hazard ratio of 1.75.
- Influence of study methodology: The association also varied according to how time-related bias was addressed. Studies using lag-time analysis reported an HR of 1.25, while those accounting for exposure as a time-varying factor reported an HR of 1.38.
The researchers highlighted that the association between PPI exposure and dementia was influenced considerably by the choice of comparison group and the statistical methods used to account for time-related biases. The absence of a significant difference when comparing PPIs directly with H2RAs also raises questions about whether the observed dementia risk is specific to PPIs.
The authors emphasised that the findings establish an association rather than causation. They called for well-designed, long-term observational studies using appropriate active comparators to determine whether PPI exposure independently contributes to dementia development.
Reference:
Ha, H., Lee, H. W., Park, J. E., Ye, B. S., Yu, Y. M., & Ah, Y. M. Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta-Analysis. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70534
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.